Rivaroxaban
Stock Recap #PipelineProspector

Pipeline Prospector Nov 2023: Lilly, Novo post sharp rise in Q3 sales; AbbVie buys ImmunoGen for US$ 10.1 billion

Through much of 2023, markets remained volatile, with pharma indices managing to inch up only in som